Wishlist: SOMAscan analysis of plasma samples from breast cancer patients
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Food and Drug Administration is forecasting a requirement for cardiotoxicity biomarker analysis of plasma samples obtained from breast cancer patients treated with doxorubicin. This project specifically involves the use of SOMAscan analysis to identify and evaluate biomarkers associated with heart toxicity resulting from chemotherapy treatments. The opportunity is categorized under NAICS code 541720 for research and development in biotechnology. Interested parties can coordinate with the Nctr Acquisition Liaison for further program details as the agency works toward determining a formal contracting officer for the procurement.
General Info
Place of Performance
USASet-Aside
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
